JP Morgan

Polyus Gold emerged with pricing for a long five year dollar bond on Wednesday morning as reports circulated of imminent supply from a pair of big Russian corporates.

The IPO of Ahlsell, the Nordic distributor of plumbing and electrical products, got covered at its maximum size within 24 hours of the launch of its bookbuild on Tuesday afternoon.

A group of banks and service providers, led by New York based start-up Axoni, have completed a test of blockchain technology and smart contracts to manage affirmations and post-trade lifecycle processing for over-the-counter equity swaps, building on similar work done earlier this year for credit derivatives.

Brazil’s biggest producer of processed food BRF has signed up as a cornerstone investor on Cofco Meat Holdings’ HK$2.59bn ($333.9m) IPO, according to a statement from the São Paulo-based company.

ZTO Express and Samsung BioLogics are seeing bumper responses for their jumbo IPOs in the US and South Korea respectively, as bankers expect their bookbuilds to gain even more momentum.

PNB Housing Finance and Varun Beverages are launching their IPOs in India next week to raise a combined Rp41.1bn ($616.9m).

JP Morgan’s credit product development group (CPD), formed in August and headed up by former syndicate global co-head Ryan O’Grady, has added seven new members.

Snam visited the euro corporate bond market for the second week in a row on Tuesday, issuing a €500m four year bond and clinching a 0% coupon for the offering.

Equate Petrochemical Company, a US and Kuwaiti joint venture, has picked banks for its debut bond issue and, despite heavy supply from Middle East borrowers, bankers have no doubt demand for the deal will be strong.

China Great Wall International Holdings III and Bank of Communications Financial Leasing Co are preparing to hit the road for their respective senior unsecured dollar offerings.

South Korea’s Samsung BioLogics gathered enough orders from investors to cover its W2.25tr ($2.0bn) IPO after the very first day of bookbuilding.

Fullerton Healthcare Corp is working with the Singapore regulator to resolve issues around its S$213.3m ($154.7m) IPO, with the delay causing some investors to consider pulling their bids.